The UBIAD1 Prenyltransferase Links Menaquione-4 Synthesis to Cholesterol Metabolic Enzymes

Michael L. Nickerson, Allen D. Bosley, Jayne S. Weiss, Brittany N. Kostiha, Yoshihisa Hirota, Wolfgang Brandt, Dominic Esposito, Shigeru Kinoshita, Ludger Wessjohann, Scott G. Morham, Thorkell Andresson, Howard S. Kruth, Toshio Okano, Michael Dean

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Schnyder corneal dystrophy (SCD) is an autosomal dominant disease characterized by germline variants in UBIAD1 introducing missense alterations leading to deposition of cholesterol in the cornea, progressive opacification, and loss of visual acuity. UBIAD1 was recently shown to synthesize menaquinone-4 (MK-4, vitamin K2), but causal mechanisms of SCD are unknown. We report a novel c.864G>A UBIAD1 mutation altering glycine 177 to glutamic acid (p.G177E) in six SCD families, including four families from Finland who share a likely founder mutation. We observed reduced MK-4 synthesis by UBIAD1 altered by SCD mutations p.N102S, p.G177R/E, and p.D112N, and molecular models showed p.G177-mutant UBIAD1 disrupted transmembrane helices and active site residues. We show UBIAD1 interacts with HMGCR and SOAT1, enzymes catalyzing cholesterol synthesis and storage, respectively, using yeast two-hybrid screening and immunoprecipitation. Docking simulations indicate cholesterol binds to UBIAD1 in the substrate-binding cleft and substrate-binding overlaps with GGPP binding, an MK-4 substrate, suggesting potential competition between these metabolites. Impaired MK-4 synthesis is a biochemical defect identified in SCD suggesting UBIAD1 links vitamin K and cholesterol metabolism through physical contact between enzymes and metabolites. Our data suggest a role for endogenous MK-4 in maintaining cornea health and visual acuity. Published 2012 Wiley Periodicals, Inc. *This article is a US Government work and, as such, is in the public domain of the United States of America.

Original languageEnglish
Pages (from-to)317-329
Number of pages13
JournalHuman Mutation
Volume34
Issue number2
DOIs
Publication statusPublished - 2013 Feb
Externally publishedYes

Keywords

  • ACAT
  • HMGCR
  • Schnyder crystalline corneal dystrophy
  • SOAT1
  • TERE1

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Nickerson, M. L., Bosley, A. D., Weiss, J. S., Kostiha, B. N., Hirota, Y., Brandt, W., ... Dean, M. (2013). The UBIAD1 Prenyltransferase Links Menaquione-4 Synthesis to Cholesterol Metabolic Enzymes. Human Mutation, 34(2), 317-329. https://doi.org/10.1002/humu.22230

The UBIAD1 Prenyltransferase Links Menaquione-4 Synthesis to Cholesterol Metabolic Enzymes. / Nickerson, Michael L.; Bosley, Allen D.; Weiss, Jayne S.; Kostiha, Brittany N.; Hirota, Yoshihisa; Brandt, Wolfgang; Esposito, Dominic; Kinoshita, Shigeru; Wessjohann, Ludger; Morham, Scott G.; Andresson, Thorkell; Kruth, Howard S.; Okano, Toshio; Dean, Michael.

In: Human Mutation, Vol. 34, No. 2, 02.2013, p. 317-329.

Research output: Contribution to journalArticle

Nickerson, ML, Bosley, AD, Weiss, JS, Kostiha, BN, Hirota, Y, Brandt, W, Esposito, D, Kinoshita, S, Wessjohann, L, Morham, SG, Andresson, T, Kruth, HS, Okano, T & Dean, M 2013, 'The UBIAD1 Prenyltransferase Links Menaquione-4 Synthesis to Cholesterol Metabolic Enzymes', Human Mutation, vol. 34, no. 2, pp. 317-329. https://doi.org/10.1002/humu.22230
Nickerson, Michael L. ; Bosley, Allen D. ; Weiss, Jayne S. ; Kostiha, Brittany N. ; Hirota, Yoshihisa ; Brandt, Wolfgang ; Esposito, Dominic ; Kinoshita, Shigeru ; Wessjohann, Ludger ; Morham, Scott G. ; Andresson, Thorkell ; Kruth, Howard S. ; Okano, Toshio ; Dean, Michael. / The UBIAD1 Prenyltransferase Links Menaquione-4 Synthesis to Cholesterol Metabolic Enzymes. In: Human Mutation. 2013 ; Vol. 34, No. 2. pp. 317-329.
@article{b0d0ad6bd2cb448a945ab195513b6c37,
title = "The UBIAD1 Prenyltransferase Links Menaquione-4 Synthesis to Cholesterol Metabolic Enzymes",
abstract = "Schnyder corneal dystrophy (SCD) is an autosomal dominant disease characterized by germline variants in UBIAD1 introducing missense alterations leading to deposition of cholesterol in the cornea, progressive opacification, and loss of visual acuity. UBIAD1 was recently shown to synthesize menaquinone-4 (MK-4, vitamin K2), but causal mechanisms of SCD are unknown. We report a novel c.864G>A UBIAD1 mutation altering glycine 177 to glutamic acid (p.G177E) in six SCD families, including four families from Finland who share a likely founder mutation. We observed reduced MK-4 synthesis by UBIAD1 altered by SCD mutations p.N102S, p.G177R/E, and p.D112N, and molecular models showed p.G177-mutant UBIAD1 disrupted transmembrane helices and active site residues. We show UBIAD1 interacts with HMGCR and SOAT1, enzymes catalyzing cholesterol synthesis and storage, respectively, using yeast two-hybrid screening and immunoprecipitation. Docking simulations indicate cholesterol binds to UBIAD1 in the substrate-binding cleft and substrate-binding overlaps with GGPP binding, an MK-4 substrate, suggesting potential competition between these metabolites. Impaired MK-4 synthesis is a biochemical defect identified in SCD suggesting UBIAD1 links vitamin K and cholesterol metabolism through physical contact between enzymes and metabolites. Our data suggest a role for endogenous MK-4 in maintaining cornea health and visual acuity. Published 2012 Wiley Periodicals, Inc. *This article is a US Government work and, as such, is in the public domain of the United States of America.",
keywords = "ACAT, HMGCR, Schnyder crystalline corneal dystrophy, SOAT1, TERE1",
author = "Nickerson, {Michael L.} and Bosley, {Allen D.} and Weiss, {Jayne S.} and Kostiha, {Brittany N.} and Yoshihisa Hirota and Wolfgang Brandt and Dominic Esposito and Shigeru Kinoshita and Ludger Wessjohann and Morham, {Scott G.} and Thorkell Andresson and Kruth, {Howard S.} and Toshio Okano and Michael Dean",
year = "2013",
month = "2",
doi = "10.1002/humu.22230",
language = "English",
volume = "34",
pages = "317--329",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - The UBIAD1 Prenyltransferase Links Menaquione-4 Synthesis to Cholesterol Metabolic Enzymes

AU - Nickerson, Michael L.

AU - Bosley, Allen D.

AU - Weiss, Jayne S.

AU - Kostiha, Brittany N.

AU - Hirota, Yoshihisa

AU - Brandt, Wolfgang

AU - Esposito, Dominic

AU - Kinoshita, Shigeru

AU - Wessjohann, Ludger

AU - Morham, Scott G.

AU - Andresson, Thorkell

AU - Kruth, Howard S.

AU - Okano, Toshio

AU - Dean, Michael

PY - 2013/2

Y1 - 2013/2

N2 - Schnyder corneal dystrophy (SCD) is an autosomal dominant disease characterized by germline variants in UBIAD1 introducing missense alterations leading to deposition of cholesterol in the cornea, progressive opacification, and loss of visual acuity. UBIAD1 was recently shown to synthesize menaquinone-4 (MK-4, vitamin K2), but causal mechanisms of SCD are unknown. We report a novel c.864G>A UBIAD1 mutation altering glycine 177 to glutamic acid (p.G177E) in six SCD families, including four families from Finland who share a likely founder mutation. We observed reduced MK-4 synthesis by UBIAD1 altered by SCD mutations p.N102S, p.G177R/E, and p.D112N, and molecular models showed p.G177-mutant UBIAD1 disrupted transmembrane helices and active site residues. We show UBIAD1 interacts with HMGCR and SOAT1, enzymes catalyzing cholesterol synthesis and storage, respectively, using yeast two-hybrid screening and immunoprecipitation. Docking simulations indicate cholesterol binds to UBIAD1 in the substrate-binding cleft and substrate-binding overlaps with GGPP binding, an MK-4 substrate, suggesting potential competition between these metabolites. Impaired MK-4 synthesis is a biochemical defect identified in SCD suggesting UBIAD1 links vitamin K and cholesterol metabolism through physical contact between enzymes and metabolites. Our data suggest a role for endogenous MK-4 in maintaining cornea health and visual acuity. Published 2012 Wiley Periodicals, Inc. *This article is a US Government work and, as such, is in the public domain of the United States of America.

AB - Schnyder corneal dystrophy (SCD) is an autosomal dominant disease characterized by germline variants in UBIAD1 introducing missense alterations leading to deposition of cholesterol in the cornea, progressive opacification, and loss of visual acuity. UBIAD1 was recently shown to synthesize menaquinone-4 (MK-4, vitamin K2), but causal mechanisms of SCD are unknown. We report a novel c.864G>A UBIAD1 mutation altering glycine 177 to glutamic acid (p.G177E) in six SCD families, including four families from Finland who share a likely founder mutation. We observed reduced MK-4 synthesis by UBIAD1 altered by SCD mutations p.N102S, p.G177R/E, and p.D112N, and molecular models showed p.G177-mutant UBIAD1 disrupted transmembrane helices and active site residues. We show UBIAD1 interacts with HMGCR and SOAT1, enzymes catalyzing cholesterol synthesis and storage, respectively, using yeast two-hybrid screening and immunoprecipitation. Docking simulations indicate cholesterol binds to UBIAD1 in the substrate-binding cleft and substrate-binding overlaps with GGPP binding, an MK-4 substrate, suggesting potential competition between these metabolites. Impaired MK-4 synthesis is a biochemical defect identified in SCD suggesting UBIAD1 links vitamin K and cholesterol metabolism through physical contact between enzymes and metabolites. Our data suggest a role for endogenous MK-4 in maintaining cornea health and visual acuity. Published 2012 Wiley Periodicals, Inc. *This article is a US Government work and, as such, is in the public domain of the United States of America.

KW - ACAT

KW - HMGCR

KW - Schnyder crystalline corneal dystrophy

KW - SOAT1

KW - TERE1

UR - http://www.scopus.com/inward/record.url?scp=84873093558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873093558&partnerID=8YFLogxK

U2 - 10.1002/humu.22230

DO - 10.1002/humu.22230

M3 - Article

VL - 34

SP - 317

EP - 329

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 2

ER -